Amalgamated Financial’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Amalgamated Financial’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$19K	Buy	+2,981	New	+$30.4K	﹤0.01%	2766

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Amalgamated Financial's OMGA Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2022: 2,981 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #2766 among its holdings.

52 funds tracked by Wall St. Rank hold OMGA as of Q1 2022.

Amalgamated Financial held 2,981 shares of Omega Therapeutics, Inc. Common Stock worth $19K as of Q1 2022.
Omega Therapeutics, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Omega Therapeutics, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2766 holding.
52 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.